Skip to content

Evaluation of the effect of HBF2020-05 intake on visual function.

Evaluation of the effect of HBF2020-05 intake on visual function. - Evaluation of the effect of HBF2020-05 intake on visual function.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045803
Enrollment
40
Registered
2021-10-20
Start date
2021-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanease adults

Interventions

Oral ingestion of HBF2020-05 once a day for 3 months Oral ingestion of the placebo control food once a day for 3 months

Sponsors

Hayashibara CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Full-time, part-time, or contract employees of Hayashibara who have been with the company for at least one year and are in good health and are between the ages of 20 and 64, and in the case of fixed-term employees, whose contract includes the test period. 2) Those who are able to come to the Fujisaki, Fujita, or Head Office areas for various measurements. 3) Those who have difficulty reading letters within 30cm of their eyes while not struggling to see far. 4) Those who do not wear bifocal glasses. 5) Those who do not work in shifts for the convenience of subject management. 6) Those who are not pregnant or may become pregnant, those who wish to become pregnant during the study period, and those who are not breast-feeding. 7) Those who have no history of eye diseases (glaucoma, cataract, etc.), surgery (including LASIK surgery), or medication. 8) In addition to 7), have no history of renal or hepatic disease, cardiac disease, respiratory disease, endocrine disease, or other metabolic disease, surgery, or medication. 9) If you are taking any supplements on a regular basis, please stop taking them during the study period.

Exclusion criteria

Exclusion criteria: None in particular

Design outcomes

Primary

MeasureTime frame
Visual function at 0, 1, 2, and 3 months of test food intake

Secondary

MeasureTime frame
Questionnaire survey at 0, 1, 2, and 3 months of test food intake

Countries

Japan

Contacts

Public ContactNaoki Morishita

Hayashibara CO., LTD. R&D Division, Development Unit

naoki.morishita@hb.nagase.co.jp0862763141

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026